Document is current
Any future updates will be listed below
-
Authors
Braniewska, Agata
Skorzynski, Marcin
Sas, Zuzanna
Dlugolecka, Magdalena
Marszalek, Ilona
Kurpiel, Daria
Bühler, Marcel
Strzemecki, Damian
Magiera, Aneta
Bialasek, Maciej
Walczak, Jaroslaw
Cheda, Lukasz
Komorowski, Michal
Weiss, Tobias
Czystowska-Kuzmicz, Małgorzata
Kwapiszewska, Karina
Boffi, Alberto
Krol, Magdalena
Rygiel, Tomasz P.
-
Funding
Funding for this research was provided by:
Fundacja na rzecz Nauki Polskiej (TEAM TECH /2016-1/8, TEAM TECH /2016-1/8, TEAM TECH /2016-1/8, TEAM TECH /2016-1/8)
Ministry of Science and Higher Education, Poland (DIALOG-0188/DLG/2018/10, DIALOG-0188/DLG/2018/10)
Narodowe Centrum Nauki (2019/35/N/ST4/01987)
National Center for Gene Therapy and Drugs based on RNA Technology (CN 00000041)
- License Information
-
More Information
Article History
Received: 20 September 2024
Accepted: 5 November 2024
First Online: 27 November 2024
Declarations
:
: Human primary monocytes were isolated from buffy coats of healthy donors obtained from the Regional Blood Center in Warsaw, Poland, with the knowledge of the Bioethics Committee at the Central Clinical Hospital of the Ministry of Interior and Administration in Warsaw (approved on12/10/2022).
: A.Boffi, M.Krol, and T.P.R. are founders and shareholders of Cellis. M.Krol, and T.P.R are members of the board of Cellis. A.Braniewska, M.S., Z.S., IM, A.Boffi, M.Krol, and T.P.R. are authors of patent applications and/or registrations related to this work. A.Braniewska, M.S., Z.S., I.M., D.K., D.S., M.B., L.C., M.Krol, and T.P.R. were or are employees of Cellis. Cellis is a company pursuing the commercial development of related technology.
